Literature DB >> 24585717

Innate immunity is sufficient for the clearance of Chlamydia trachomatis from the female mouse genital tract.

Gail L Sturdevant1, Harlan D Caldwell.   

Abstract

Chlamydia muridarum and Chlamydia trachomatis, mouse and human strains, respectively, have been used to study immunity in a murine model of female genital tract infection. Despite evidence that unique genes of these otherwise genomically similar strains could play a role in innate immune evasion in their respective mouse and human hosts, there have been no animal model findings to directly support this conclusion. Here, we infected C57BL/6 and adaptive immune-deficient Rag1(-/-) female mice with these strains and evaluated their ability to spontaneously resolve genital infection. Predictably, C57BL/6 mice spontaneously cleared infection caused by both chlamydial strains. In contrast, Rag1(-/-) mice which lack mature T and B cell immunity but maintain functional innate immune effectors were incapable of resolving C. muridarum infection but spontaneously cleared C. trachomatis infection. This distinct dichotomy in adaptive and innate immune-mediated clearance between mouse and human strains has important cautionary implications for the study of natural immunity and vaccine development in the mouse model.
© 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  Chlamydiae; Rag−/− mice; adaptive immunity; female genital tract; human and mouse strains; innate immunity

Mesh:

Year:  2014        PMID: 24585717      PMCID: PMC4152394          DOI: 10.1111/2049-632X.12164

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  23 in total

Review 1.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  Epidemiology of chlamydial infection: are we losing ground?

Authors:  M L Rekart; R C Brunham
Journal:  Sex Transm Infect       Date:  2008-01-23       Impact factor: 3.519

3.  Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells.

Authors:  Christine Roshick; Heidi Wood; Harlan D Caldwell; Grant McClarty
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections--2002.

Authors:  Robert E Johnson; Wilbert J Newhall; John R Papp; Joan S Knapp; Carolyn M Black; Thomas L Gift; Richard Steece; Lauri E Markowitz; Owen J Devine; Cathleen M Walsh; Susan Wang; Dorothy C Gunter; Kathleen L Irwin; Susan DeLisle; Stuart M Berman
Journal:  MMWR Recomm Rep       Date:  2002-10-18

5.  Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae.

Authors:  T D Read; G S A Myers; R C Brunham; W C Nelson; I T Paulsen; J Heidelberg; E Holtzapple; H Khouri; N B Federova; H A Carty; L A Umayam; D H Haft; J Peterson; M J Beanan; O White; S L Salzberg; R-c Hsia; G McClarty; R G Rank; P M Bavoil; C M Fraser
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

6.  Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract.

Authors:  Gail L Sturdevant; Laszlo Kari; Donald J Gardner; Norma Olivares-Zavaleta; Linnell B Randall; William M Whitmire; John H Carlson; Morgan M Goheen; Elizabeth M Selleck; Craig Martens; Harlan D Caldwell
Journal:  Infect Immun       Date:  2010-06-14       Impact factor: 3.441

7.  CDC Grand Rounds: Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-04-01       Impact factor: 17.586

Review 8.  Chlamydia trachomatis control requires a vaccine.

Authors:  Robert C Brunham; Rino Rappuoli
Journal:  Vaccine       Date:  2013-01-29       Impact factor: 3.641

9.  Genital-tract infection and disease in nude and immunologically competent mice after inoculation of a human strain of Chlamydia trachomatis.

Authors:  M Tuffrey; P Falder; D Taylor-Robinson
Journal:  Br J Exp Pathol       Date:  1982-10

10.  A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis.

Authors:  A L Barron; H J White; R G Rank; B L Soloff; E B Moses
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

View more
  24 in total

1.  Mutational Analysis of the Chlamydia muridarum Plasticity Zone.

Authors:  Krithika Rajaram; Amanda M Giebel; Evelyn Toh; Shuai Hu; Jasmine H Newman; Sandra G Morrison; Laszlo Kari; Richard P Morrison; David E Nelson
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

2.  Complement factor C5 but not C3 contributes significantly to hydrosalpinx development in mice infected with Chlamydia muridarum.

Authors:  Zhangsheng Yang; Turner Conrad; Zhou Zhou; Jianlin Chen; Pavel Dutow; Andreas Klos; Guangming Zhong
Journal:  Infect Immun       Date:  2014-05-19       Impact factor: 3.441

3.  Antibody, but not B-cell-dependent antigen presentation, plays an essential role in preventing Chlamydia systemic dissemination in mice.

Authors:  Priyangi A Malaviarachchi; Miguel A B Mercado; Stephen J McSorley; Lin-Xi Li
Journal:  Eur J Immunol       Date:  2020-03-12       Impact factor: 5.532

4.  Innate Lymphoid Cells Are Required for Endometrial Resistance to Chlamydia trachomatis Infection.

Authors:  Hong Xu; Xin Su; Yujie Zhao; Lingli Tang; Jianlin Chen; Guangming Zhong
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

5.  Transcervical Inoculation with Chlamydia trachomatis Induces Infertility in HLA-DR4 Transgenic and Wild-Type Mice.

Authors:  Sukumar Pal; Delia F Tifrea; Guangming Zhong; Luis M de la Maza
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

6.  T Cell-Independent Gamma Interferon and B Cells Cooperate To Prevent Mortality Associated with Disseminated Chlamydia muridarum Genital Tract Infection.

Authors:  Taylor B Poston; Catherine M O'Connell; Jenna Girardi; Jeanne E Sullivan; Uma M Nagarajan; Anthony Marinov; Amy M Scurlock; Toni Darville
Journal:  Infect Immun       Date:  2018-06-21       Impact factor: 3.441

7.  Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.

Authors:  Karuna P Karunakaran; Hong Yu; Xiaozhou Jiang; Queenie Chan; Kyung-Mee Moon; Leonard J Foster; Robert C Brunham
Journal:  Vaccine       Date:  2015-03-01       Impact factor: 3.641

8.  CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice.

Authors:  Mark T Zafiratos; Srikanth Manam; Kyle K Henderson; Kyle H Ramsey; Ashlesh K Murthy
Journal:  Pathog Dis       Date:  2015-07-27       Impact factor: 3.166

9.  Fluorescence-Reported Allelic Exchange Mutagenesis-Mediated Gene Deletion Indicates a Requirement for Chlamydia trachomatis Tarp during In Vivo Infectivity and Reveals a Specific Role for the C Terminus during Cellular Invasion.

Authors:  Susmita Ghosh; Elizabeth A Ruelke; Joshua C Ferrell; Maria D Bodero; Kenneth A Fields; Travis J Jewett
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

Review 10.  Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis.

Authors:  Hong Yu; Karuna P Karunakaran; Xiaozhou Jiang; Robert C Brunham
Journal:  Expert Rev Vaccines       Date:  2016-03-21       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.